Your browser is no longer supported. Please, upgrade your browser.
AVCO Avalon GloboCare Corp. monthly Stock Chart
Avalon GloboCare Corp.
Index- P/E- EPS (ttm)-0.19 Insider Own65.73% Shs Outstand80.62M Perf Week5.88%
Market Cap103.40M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float27.90M Perf Month11.50%
Income-15.00M PEG- EPS next Q- Inst Own3.30% Short Float8.70% Perf Quarter-14.29%
Sales1.40M P/S73.85 EPS this Y-122.80% Inst Trans-0.91% Short Ratio6.33 Perf Half Y-21.74%
Book/sh0.07 P/B18.00 EPS next Y- ROA-140.60% Target Price- Perf Year-15.44%
Cash/sh0.02 P/C73.85 EPS next 5Y- ROE-329.20% 52W Range0.50 - 2.50 Perf YTD-34.72%
Dividend- P/FCF- EPS past 5Y- ROI-251.70% 52W High-49.60% Beta0.57
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin32.60% 52W Low152.00% ATR0.06
Employees8 Current Ratio0.90 Sales Q/Q-25.00% Oper. Margin- RSI (14)58.94 Volatility5.20% 5.76%
OptionableNo Debt/Eq0.00 EPS Q/Q20.90% Profit Margin- Rel Volume0.77 Prev Close1.27
ShortableYes LT Debt/Eq0.62 Earnings- Payout- Avg Volume383.49K Price1.26
Recom- SMA205.79% SMA505.44% SMA200-13.40% Volume294,117 Change-0.79%
Nov-16-20 11:37PM  
Oct-22-20 08:30AM  
Sep-03-20 11:11AM  
Sep-01-20 10:24AM  
Aug-19-20 11:03AM  
Aug-12-20 09:00AM  
Jul-13-20 09:00AM  
Jul-03-20 02:37PM  
Jun-29-20 09:30AM  
Jun-25-20 09:00AM  
Jun-16-20 09:00AM  
Jun-11-20 09:00AM  
Jun-08-20 09:00AM  
May-08-20 09:00AM  
Apr-28-20 09:00AM  
Apr-20-20 08:30AM  
Feb-24-20 08:30AM  
Feb-04-20 09:00AM  
Jan-14-20 06:38AM  
Jan-06-20 08:30AM  
Dec-20-19 08:30AM  
Nov-20-19 08:30AM  
Nov-15-19 05:26AM  
Oct-21-19 08:00AM  
Sep-19-19 08:00AM  
Sep-17-19 03:04PM  
Sep-03-19 08:00AM  
Jul-22-19 09:00PM  
Jul-15-19 08:00AM  
Jun-26-19 08:30AM  
Jun-18-19 08:00AM  
Jun-13-19 08:00AM  
Jun-10-19 08:00AM  
May-21-19 09:00AM  
Apr-25-19 08:58AM  
Apr-24-19 08:00AM  
Apr-17-19 08:00AM  
Apr-08-19 08:35AM  
Mar-06-19 08:00AM  
Feb-26-19 08:00AM  
Feb-11-19 08:30AM  
Feb-04-19 08:15AM  
Jan-29-19 10:29AM  
Jan-28-19 08:45AM  
Jan-23-19 01:44PM  
Jan-16-19 04:00PM  
Jan-15-19 08:00AM  
Jan-03-19 09:00AM  
Dec-26-18 10:43AM  
Dec-19-18 08:00AM  
Nov-13-18 09:05AM  
Nov-05-18 09:00AM  
Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States and the People's Republic of China. The company offers medical related consulting services, including research studies, executive education, daily online executive briefings, tailored expert advisory services, and consulting and management services in the areas of immunotherapy and second opinion/referral services. It also develops Avalon Cell and Avalon Rehab platforms that cover the areas of regenerative medicine, cell-based immunotherapy, and exosome technology. In addition, the company develops proprietary diagnostic and therapeutic products leveraging exosome technology; and provides development services for hospitals. The company has a strategic partnership with Weill Cornell Medical College to co-develop bio-production and standardization procedures for chimeric antigen receptor (CAR)-T Therapy; GensKey Medical Technology Co. Ltd. to co-develop and commercialize point-of-care, rapid detection antibody tests to identify whether a patient has been exposed to and has developed antibodies against SARS-CoV-2; GE Healthcare to enhance standardized automation and bio-production for cellular medicines; and HydroPeptide, LLC to co-develop and commercialize various clinical-grade, exosome-based cosmeceutical and orthopedic products, as well as research agreement with Massachusetts Institute of Technology to develop CAR technology. Avalon GloboCare Corp. is headquartered in Freehold, New Jersey.